The four insulin-binding mAbs isolated here, from insulin-therapy naïve Stage 1 T1D individuals, used various heavy and light chain genes, with IGHV3-15 expressed in 3/4 mAbs and no overlap in variable light chain (VL) genes (Table 2). This evidence concerns the gene INS and type 1 diabetes mellitus.